AGA Family of Websites:

FMT and Other Gut Microbial Therapies National Registry

The AGA FMT and Other Gut Microbial Therapies National Registry will assess short- and long-term patient outcomes associated with FMT and other microbial therapies. This registry is a program of the AGA Institute and AGA Center for Gut Microbiome Research & Education.

If you perform fecal microbiota transplantation (FMT), we encourage you to participate in this national data collection project. Our goal is to track 2,200 patients for 10 years. The data we collect will allow us to identify potential short-term adverse outcomes and to search for long-term safety concerns, such as development of chronic conditions like irritable bowel syndrome, obesity and diabetes. Please contribute to advancing the future of FMT — the information available to you and your patients at the end of this initiative will be worth it.

News about the AGA FMT and Other Gut Microbial Therapies National Registry

On Nov. 30, 2022, FDA approved the first fecal microbiota therapy for recurrent CDI, Rebyota®. FDA also issued new requirements for stool banks and health care professionals using FMT material.

Published in Gastroenterology, the registry reported that FMT led to a cure of C. difficile infection in 90% of patients across 20 North American FMT practice sites. Few serious side effects were reported.

With this milestone, the FMT registry is officially underway. The AGA FMT National Registry also announces collaborations with American Gut and OpenBiome.

In this article Genome Magazine profiles AGA’s Fecal Microbiota Transplantation National Registry, which will be the largest data set of long-term outcomes for this procedure.

In this Gastroenterology commentary, the registry co-principal investigators discuss the impetus and goals for this massive data collection initiative.

Patient information on the AGA FMT and Other Gut Microbial Therapies National Registry

Visit to see the sites participating in this registry. You or your doctor can contact the participating sites to learn more about enrolling.

Visit this page for frequently asked questions and other information relevant to patients who have already received a FMT.

This information will help you understand if fecal microbiota transplantation is right for you.

Watch this brief video to hear as leading experts in the field explain what are fecal transplants and how they’ve changed the treatment of recurring C. difficile infection.

More on the AGA FMT and Other Gut Microbial Therapies National Registry

Hear from Loren Laine, MD, AGAF, Colleen Kelly, MD, and Gary Wu, MD, co-principal investigators for AGA’s NIH-funded FMT registry, as they explain how this registry will influence future practice and research of FMT.

Meet our funder

This project is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R24AI118629.

The content on this website is solely the responsibility of the American Gastroenterological Association and does not necessarily represent the official views of the National Institutes of Health.

Meet our partner societies

Meet our registry collaborators

Meet our steering committee

The FMT Registry Steering Committee oversees registry operations, ensures compliance with clinical protocol and applicable regulations, and provides general direction for the registry.

Picture of Colleen Kelly, MD

Colleen Kelly, MD

Co-Chair and Prinicipal Investigator,
Brown University Women's Medicine and Collaborative

Picture of Loren Laine, MD, AGAF

Loren Laine, MD, AGAF

Co-Chair and Co-Principal Investigator,
Yale School of Medicine

Picture of Gary Wu, MD

Gary Wu, MD

Co-Principal Investigator,
University of Pennsylvania

Picture of Ashish Atreja, MD, MPH

Ashish Atreja, MD, MPH

Health Information Technology Expert,
UC Davis Health

Picture of Stacy Kahn, MD

Stacy Kahn, MD

Boston Children’s Hospital

Picture of James Lewis, MD, MSCE, AGAF

James Lewis, MD, MSCE, AGAF

Clinical Epidemiology Expert,
University of Pennsylvania

Picture of Brendan J. Kelly, MD, MS

Brendan J. Kelly, MD, MS

IDSA Liaison,
University of Pennsylvania

Picture of Andres Hurtado-Lorenzo, PhD

Andres Hurtado-Lorenzo, PhD

CCF Liaison,
Crohn's & Colitis Foundation

Picture of Alexander Khoruts, MD

Alexander Khoruts, MD

FMT and Microbiota-Based Therapeutics Expert,
University of Minnesota

Picture of Gail Hecht, MD

Gail Hecht, MD

Clinical Microbiology Expert,
Loyola University Medical Center

Picture of Rob Knight, PhD

Rob Knight, PhD

Microbiome Analytics Expert,
University of California, San Diego

Brought to you by the

AGA Center for Gut Microbiome Research & Education